Navigation Links
Daily bathroom showers may deliver face full of pathogens, says CU-Boulder study
Date:9/14/2009

try is frankly archaic. The tools now exist to monitor it far more accurately and far less expensively that what is routinely being done today."

In 2001 the National Academy of Sciences awarded Pace the Selman Waxman Award -- considered the nation's highest award in microbiology -- for pioneering the molecular genetic techniques he now uses to rapidly detect, identify and classify microbe species using nucleic acid technology without the need for lab cultivation. That same year he was awarded a MacArthur Foundation "genius grant" for his work.


'/>"/>

Contact: Norman Pace
norman.pace@colorado.edu
303-735-1864
University of Colorado at Boulder
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. Individual cells isolated from biological clock can keep daily time, but are unreliable
2. Daily consumption of cannabis predisposes to the appearance of psychosis and schizophrenia
3. Blood pressure response to daily stress provides clues for better hypertension treatment
4. U of M finds teens who eat breakfast daily eat healthier diets than those who skip breakfast
5. Encap agrees colonic drug delivery licensing deal
6. Finding the ZIP-code for gene therapy: Scientists imitate viruses to deliver therapeutic genes
7. U-Iowa improves delivery of cancer-fighting molecules
8. UCSB scientists discover potential drug delivery system
9. New cancer drug delivery system is effective and reversible
10. Nanoparticle-delivered suicide genes slowed ovarian tumor growth
11. Nanodiamonds deliver insulin for wound healing
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Daily bathroom showers may deliver face full of pathogens, says CU-Boulder study
(Date:6/25/2015)... CITY , June 25, 2015  Imagine a ... steps toward a healthier, happier life. That,s exactly what ... designed to do. The cutting-edge, portable health program provides ... real-life solutions to help improve your lifestyle and nutrition. ... awards dinner and gala Wednesday night, USANA,s THA was ...
(Date:6/24/2015)... YORK , June 24, 2015 This ... market, over the next six years. It contains an ... the industry, along with their impact from the short, ... It also discusses the industry, market, and technology trends ... that the need of concerned authorities to efficiently manage ...
(Date:6/24/2015)... 2015 Biometry authentication provider KeyLemon today ... solution one face in. Logo ... face in, entering the expanding biometric authentication market ... biometric answer to the password problem. With advanced ... with KeyLemon, one face in allows users to ...
Breaking Biology News(10 mins):@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
... ancient mitochondrial DNA (mtDNA) has been used to establish ... the time before Christopher Columbus sailed to the Americas. ... BMC Genetics has used more detailed DNA ... family relationships and burial traditions of ancient Peru. ...
... SAN DIEGO With more than 1.7 million people ... to identify processes to limit inflammation and subsequent damage ... traumatic brain injury, leaving 85,000 with long-term disabilities and ... 5 million people live with disabilities caused by traumatic ...
... SAN DIEGO Heart failure is the most common ... of chronic high blood pressure, also known as hypertension. ... array of approaches aimed at preventing and treating high ... an anti-hypertensive drug, moxonidine, which acts on the imidazoline ...
Cached Biology News:Forensic science used to determine who's who in pre-Columbian Peru 2Estrogen hormone reveals protective ability after traumatic brain injury 2Second-generation drug used for hypertension aids heart function independent of blood pressure 2
(Date:7/1/2015)... Calif. , July 1, 2015   ... on the development of groundbreaking drugs to treat ... announced today that Robert G. Miller , ... at Sutter Health,s California Pacific Medical Center in San ... ALS Association for $1.5 million to help fund ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Apex Therapeutics ... BIO International Convention in Philadelphia, PA. , The presentation took place on ... outlined the plans for the development of APX3330 for the treatment of pancreatic cancer. ...
(Date:6/30/2015)... - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that ... approved the resolutions relating to: (i) a private ... at a price of $2.67 per unit (the ... one common share and 0.075358 common share purchase ... and (ii) the amendment to Resverlogix,s articles to ...
(Date:6/30/2015)... ... 30, 2015 , ... uBiome and OpenBiome Partner for Microbiome ... fecal microbiota transplantation in C. difficile patients. , SAN FRANCISCO, uBiome and OpenBiome ... microbiota transplantation (FMT) as a treatment for Clostridium difficile infections (C. diff). , ...
Breaking Biology Technology:Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3
... Morria Biopharmaceuticals,Plc, a biopharmaceutical company focused on ... ICH compliant Phase II equivalent,multi-center study of MRX-4 ... given as an intranasal spray formulation., The ... allergic,rhinitis patients outside of the local allergy season. ...
... new apoA1 measurement and apoB:apoA1 ratio to its, comprehensive cholesterol ... ... heart disease, BIRMINGHAM, Ala., Nov. 6 Atherotech, ... Test in booth No. 2918 at the American Heart Association,Scientific Sessions ...
... 6 Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: NTII ) ... 30, 2008, the first quarter of the,company,s fiscal year ... September 30, 2008 was $3.6 million, compared to $3.9 ... expenses were $6.8 million,for the first quarter of fiscal ...
Cached Biology Technology:Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients 2Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients 3Atherotech to Exhibit VAP(R) Cholesterol Test at American Heart Association Scientific Sessions 2008 2Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results 2Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results 3Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results 4Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results 5